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Summary 25 
1. Wildlife disease surveillance is the first line of defence against infectious disease. Fluctuations in 26 
host populations and disease prevalence are a known feature of wildlife disease systems. 27 
However, the impact of such heterogeneities on the performance of surveillance is currently 28 
poorly understood.    29 
2. We present the first systematic exploration of the effects of fluctuations’ prevalence and host 30 
population size on the efficacy of wildlife disease surveillance systems. In this study efficacy is 31 
measured in terms of ability to estimate long-term prevalence and detect disease risk. 32 
3. Our results suggest that for many wildlife disease systems fluctuations in population size and 33 
disease lead to bias in surveillance-based estimates of prevalence and over-confidence in 34 
assessments of both the precision of prevalence estimates and the power to detect disease.  35 
4. Neglecting such ecological effects may lead to poorly designed surveillance and ultimately to 36 
incorrect assessments of the risks posed by disease in wildlife. This will be most problematic in 37 
systems where prevalence fluctuations are large and disease fade-outs occur. Such fluctuations 38 
are determined by the interaction of demography and disease dynamics. Although particularly 39 
likely in highly fluctuating populations typical of fecund short-lived hosts, such fluctuations 40 
cannot be ruled out in more stable populations of longer-lived hosts. 41 
5. Synthesis and applications. Fluctuations in population size and disease prevalence should be 42 
considered in the design and implementation of wildlife disease surveillance and the framework 43 
presented here provides a template for conducting suitable power calculations. Ultimately 44 
understanding the impact of fluctuations in demographic and epidemiological processes will 45 
enable improvements to wildlife disease surveillance systems leading to better characterization 46 
of, and protection against endemic, emerging and re-emerging disease threats. 47 
Key-words: wildlife disease systems, wildlife ecology, disease surveillance, demographic 48 
fluctuations, wildlife populations, disease transmission models, stochastic population models  49 
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Introduction 50 
Surveillance is the first line of defence against disease, whether to monitor endemic cycles of 51 
infection (Ryser-Degiorgis 2013) or to detect incursions of emerging or re-emerging diseases (Kruse, 52 
Kirkemo & Handeland 2004; Lipkin 2013)). Identification and quantification of disease presence and 53 
prevalence is the starting point for developing disease control strategies as well as monitoring their 54 
efficacy (OIE 2013). Knowledge of disease in wildlife is of considerable importance for managing risks 55 
to humans (Daszak, Cunningham & Hyatt 2000; Jones et al. 2008) and livestock (Gortázar et al. 56 
2007), as well as for the conservation of wildlife species themselves (Daszak, Cunningham & Hyatt 57 
2000).  58 
 59 
Recent public health concerns e.g. Highly Pathogenic Avian Influenza (Artois et al. 2009b) , Alveolar 60 
Echinococcosis (Eckert & Deplazes 2004) and West Nile Virus (Brugman et al. 2013) ), have led to a 61 
growing recognition that current approaches need to be improved (Mörner et al. 2002). For 62 
example, there is no agreed wildlife disease surveillance protocol shared among the countries in the 63 
European Union (Kuiken et al. 2011). Furthermore several authors have identified the need for 64 
improvements to the structure, understanding and evaluation of wildlife disease surveillance (Bengis 65 
et al. 2004; Gortázar et al. 2007).     66 
 67 
Much current practice for wildlife disease surveillance (Artois et al. 2009a) is based on ideas 68 
developed for surveillance in livestock, including calculation of sample sizes needed for accurate 69 
prevalence estimation (Grimes & Schulz 1996; Fosgate 2005) and detection of disease within a 70 
population (Dohoo, Martin & Stryhn 2005). A common feature of these methods is that they assume 71 
constant host populations and disease prevalence. These assumptions lead naturally to sample size 72 
calculations (for both disease detection and prevalence estimation) which are based on a binomial 73 
distribution and associated corrections for populations of finite size, such as the hyper-geometric 74 
distribution (Artois et al. 2009a). Fosgate (2009) reviewed current approaches to sample size 75 
4 
 
calculations in livestock systems and emphasized the importance of basing analyses on realistic 76 
assumptions about the system under surveillance.   77 
  78 
Although constant population size and prevalence may often be reasonable assumptions for the 79 
analysis of livestock systems, they are considerably less tenable in wildlife disease systems, which 80 
are typically subject to much greater fluctuations in host population density and disease prevalence.  81 
Both sampling practicalities and changes in population density make it much harder to obtain a 82 
random sample of hosts of the desired sample size in wildlife disease surveillance programmes 83 
(Nusser et al. 2008), compared with livestock systems.  It is not uncommon for wildlife disease 84 
surveillance to extend over several years and to test only a small fraction of the at-risk population. 85 
For example, McGarry and co-workers report overall prevalence of zoonotic helminths in 42 brown 86 
rats Rattus norvegicus captured in a programme of active surveillance carried out in an urban area in 87 
England between 2008 and 2011 (McGarry et al. 2014). These authors also present comparable 88 
results from several studies in Europe and North America while another of the same host species 89 
conducted over a two year period across a broad area of north-western England captured just 133 90 
individuals (Pounder et al. 2013). A notable example of passive surveillance i.e. the testing of found 91 
dead individuals, is that for zoonotic West Nile Virus (WNV) in wild birds across the whole of Great 92 
Britain during 2002–2009 in which only 2072 individuals representing 240 species were tested 93 
(Brugman et al. 2013).     94 
 95 
The importance of temporal (Renshaw 1991; Wilson & Hassell 1997), spatial (Lloyd & May 1996; 96 
Tilman & Kareiva 1997) and other forms of heterogeneity (Read & Keeling 2003; Vicente et al. 2007; 97 
Davidson, Marion & Hutchings 2008) in population ecology has long been recognized (Anderson 98 
1991; Smith et al. 2005), along with their role in the dynamics and persistence of infectious disease 99 
(Fenton et al. 2015). Detailed field observations have provided valuable insights into the temporal 100 
dynamics of wildlife disease systems.  For example a study (Telfer et al. 2002) of cowpox virus in two 101 
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rodent host species at two sites over a four-year period reveals strong temporal fluctuations in both 102 
population size and disease prevalence including disease fade-out (local extinction and re-103 
emergence). Fade-outs are also observed in wildlife populations of longer lived mammals as shown 104 
by a six-year study (Hawkins et al. 2006) of Devil Facial Tumour Disease in Sarcophilus harrisii 105 
Tasmanian devil.  One of the longest running and most intensive studies of disease in wildlife is the 106 
surveillance from 1982 to the present of TB in badgers at Woodchester Park, England where around 107 
80% of the population is trapped tested and released annually (Delahay et al. 2000). These long-108 
term observations have revealed important insights into the dynamics of TB in badgers e.g. that 109 
infection within social groups is persistent whereas transmission between social groups is limited 110 
(Delahay et al. 2000). Parameter estimates derived from this study are used as a reference point for 111 
the simulation studies conducted below.  112 
 113 
Despite these theoretical and empirical studies of temporal heterogeneities in wildlife disease 114 
systems, such effects have yet to be systematically accounted for, either in the design of surveillance 115 
programmes for wildlife disease systems, or in the analysis of the data obtained from them.  Here 116 
we address this gap by using a non-spatial simulation model of a wildlife host population, subject to 117 
demographic fluctuations and pathogen transmission, in order to explore the impact of stochastic 118 
fluctuations in host demography and disease dynamics on the performance of surveillance. Two 119 
measures of surveillance performance are considered; estimation of long-term prevalence and the 120 
ability (probability) to detect disease. Our results show that temporal fluctuations in wildlife disease 121 
systems limit the ability of surveillance to achieve both. 122 
 123 
Materials and methods 124 
We develop a generic modelling framework that represents key features of surveillance in wildlife 125 
disease systems including essential aspects of demography, disease dynamics and surveillance 126 
design. This framework is described below along with three simulation studies that enable us to 127 
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explore the performance of surveillance across a wide range of scenarios representative of real 128 
world systems.  129 
Stochastic modelling framework  130 
The model represents a host population subject to demographic fluctuations (births, deaths and 131 
immigration) and the transmission of a single pathogen. At each point in time t, the state-space 132 
represents the total population size N(t), with I(t) of these infected and S(t) = N(t) - I(t) 133 
susceptible. The prevalence is then given by p(t) = I(t)/N(t).  134 
Demography. The birth rate of individuals is logistic, rN(1 – N/k), with intrinsic growth rate r and 135 
carrying capacity k, reflecting the assumptions that population growth is resource-limited. 136 
Individuals have a per capita death rate µ and immigration occurs at a constant rate ν. 137 
Disease dynamics. A proportion γ of immigrants are infected, but otherwise all individuals enter the 138 
population (through birth or immigration) as susceptible, since we assume vertical and pseudo-139 
vertical transmission are negligible. Susceptible individuals become infected at rate β0 S(t) through 140 
primary transmission (contact with infectious environmental sources including individuals outside 141 
the modelled population) and at rate βS(t)I(t) by secondary transmission (contact with already 142 
infected individuals from within the population).  143 
Disease surveillance. During a single period of surveillance (surveillance bout), individuals are 144 
captured at per capita rate α, tested and released, and both the total number, and the number of 145 
infected individuals caught are recoded. Perfect diagnostic tests are assumed although limited 146 
sensitivities and specificities could be accounted for. A surveillance bout continues until a defined 147 
sample size m is obtained or some upper time limit has been reached. Such surveillance is most 148 
naturally considered in the context of active capture campaigns but could also be adapted to 149 
samples obtained from hunting and passive surveillance by accounting for the losses and sources of 150 
bias associated with such surveillance methods (see e.g. McElhinney et al. 2014). 151 
 152 
 153 
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Model implementation. The model framework is summarized in Table 1. Reported results are 154 
temporal averages (e.g. expected mean E[N] and variance Var[N] in population size) based on long 155 
run simulations following a burn-in period to allow the population to reach equilibrium where the 156 
effects of initial conditions are negligible. Within each run repeated surveillance bouts are simulated 157 
and the probability of detection PD is estimated as the proportion of bouts where disease is 158 
detected. The mean E[p̂surv] and variance Var[p̂surv] of the prevalence estimates averaged over 159 
repeated bouts are also recorded. We consider a continuous state-space implementation simulated 160 
by numerically integrating a set of stochastic differential equations (SDEs) and a discrete state-space 161 
implementation using the Gillespie algorithm (see Appendix S1 in Supporting Information for 162 
details). 163 
Simulation studies 164 
Study 1 (results shown in Fig.1 and Fig.3) uses the SDE implementation and is designed to explore a 165 
generic but representative range of wildlife disease systems. Simulations were run for four values 166 
(0.01, 0.04, 0.1, 1.0) of the secondary transmission rate β.  In each case the population death rate µ 167 
was varied over a wide range between 0.1 and 0.5, with the intrinsic growth rate set at r =0.5 so 168 
that, at the upper end of this range, populations are highly unstable. This gives rise to typical 169 
population sizes of 10–40 (see Fig.1a) and a wide range of disease prevalence. Similar results are 170 
obtained from simulations (not shown) where β is varied for a set of fixed values of µ where 171 
mortality rates span the interval (0, r). Simulations not included here show that our results 172 
generalize, holding for transmission rates relative to a recovery rate (governing an additional 173 
transition from I to S) and death rates relative to birth rate, r. Different intensities of surveillance 174 
were simulated using four capture rates α (0.01,0.1,1.0, 10), for a sample size m=10. Full 175 
parameterizations for Fig.1 and Fig. 3 are shown in Tables S3 and S6 respectively. 176 
Study 1a (results shown in Fig. 2) explores the effect of surveillance design using a subset of the 177 
parameter sets considered in study 1, namely (β, µ)=: (1.0, 0.43);  (1.0, 0.4);  and (0.1, 0.43). For 178 
each, a range of capture rates α =0…10 (with m=10) and a range of sample sizes m=1, …, 179 
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10000 (with α =0.1) are considered.  The values of all model parameters used are shown in Tables 180 
S4 and S5. 181 
Relevance to real wildlife disease systems.  The intrinsic annual growth and death rates for badgers 182 
have been estimated as r=0.6 and µ=0.4  (Anderson & Trewhella 1985). Rescaling for r=0.5 as used 183 
in simulation study 1 corresponds to a rescaled µ=0.33.  In addition the secondary transmission rate 184 
for TB in badger populations was been estimated by the same authors to be β=0.06-0.08 assuming 185 
a density of badgers necessary for disease persistence is  ~5 badgers km-2  (Anderson & Trewhella 186 
1985).  The population size considered in simulation study 1 therefore corresponds to a surveillance 187 
area of around 8 km2. The range of parameters considered in study 1 places badgers towards the 188 
stable end of the spectrum. More fecund and shorter-lived species would be expected to be less 189 
stable e.g. have higher mortality and secondary transmission rates.  As noted earlier surveillance of 190 
badgers at Woodchester Park is relatively intensive leading to an annual probability of capture of 191 
around 80% corresponding to capture rates of α=1.6–2.2 (Delahay et al. 2000).  The population of 192 
Sarcophilus harrisii Tasmanian devil discussed earlier consisted of between 20–60 individuals and 193 
was subject to annual capture rates between 0.5 and 1.7 (Hawkins et al. 2006). Estimates of capture 194 
rates are not available for the larger-scale studies referred to in the introduction (Brugman et al. 195 
2013; Pounder et al. 2013; McGarry et al. 2014), but given the sample sizes obtained and the 196 
temporal and geographic scales involved it seems reasonable to assume that they are considerably 197 
lower.  Simulation study 1 encompasses a wide range of real world wildlife disease surveillance. 198 
Study 2 (results shown in Fig. 4) is designed to test the robustness of study 1 by exploring a wider 199 
range of scenarios: with intrinsic growth rates in the range (0,23); mortality rates in the range 200 
(0.25,14), carrying capacities in the range (0,36) and secondary contact rates in the range (0.01,5).  201 
Focussed on disease detection, results are conditioned on the presence of disease and simulations 202 
based on the Gillespie implementation, which explicitly handles the discrete nature of small 203 
populations.  The values of all model parameters used in Fig. 4 are shown in Table S7.    204 
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Results 205 
Estimating prevalence 206 
In order to develop an understanding of the properties of wildlife disease surveillance using the 207 
above model, we developed expressions describing prevalence estimates obtained by continuous 208 
surveillance, i.e. continuously deployed effort resulting in per capita capture rate α. 209 
 210 
Consider the interval [0,T] during which the population history is ℋ[0,T ] = {(N(t ),p(t )): t Є [0,T]}, 211 
where N(t) and p(t) represent the population size and disease prevalence at time t Є [0,T] 212 
respectively (see above). Let nT represent the total number, and iT the number of infected 213 
individuals sampled during this time interval. Conditional on the history ℋ[0,T ], the expectations of 214 
these quantities are: 215 
 216 
E[𝑛𝑇| ℋ[0, 𝑇]] =  ∫ 𝛼𝑁(𝑡) 𝑑𝑡
𝑇
0
   and    E[𝑖𝑇| ℋ[0, 𝑇]] =  ∫ 𝛼𝑁(𝑡)𝑝(𝑡) 𝑑𝑡
𝑇
0
. 217 
 218 
The surveillance estimate of disease prevalence is simply the ratio p̂surv(T ) = iT/nT.   Since 219 
immigration prevents extinction of the population and disease then the long time limit of this 220 
estimate can be equated with its expectation over all histories as follows:  221 
lim
𝑇→∞
?̂?𝑠𝑢𝑟𝑣(𝑇) = E[?̂?𝑠𝑢𝑟𝑣] = lim
𝑇→∞
 
1
𝑇
∫ 𝑁(𝑡)𝑝(𝑡) 𝑑𝑡
𝑇
0
1
𝑇
∫ 𝑁(𝑡) 𝑑𝑡
𝑇
0
=
E[𝑁(𝑡)𝑝(𝑡)]
E[𝑁(𝑡)]
. 222 
 223 
This can be re-expressed in the more suggestive form: 224 
 225 
E[?̂?𝑆𝑢𝑟𝑣] =  E[𝑝(𝑡)] +  
𝐶𝑜𝑣[𝑁(𝑡), 𝑝(𝑡)]
E[𝑁(𝑡)]
    (eqn 1) 226 
 227 
Thus, when the covariance Cov[N(t),p(t )] = E[N(t )p(t )] - E[N(t )]E[p(t )] between the 228 
population size and the prevalence is non-zero, the surveillance estimate of prevalence is a biased 229 
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estimate of the true prevalence, E[p(t)]. Since Cov[N(t),p(t)] will be zero when either N(t) or p(t) 230 
are constant, we conclude that demographic fluctuations and stochasticity in disease dynamics 231 
undermine the efficacy of surveillance.                  232 
Effect of host demography and disease dynamics 233 
Fig. 1 is based on simulation study 1 (see Materials and methods) and illustrates how population 234 
fluctuations and disease dynamics in the host–pathogen system affect the bias and variance of 235 
estimated prevalence. These results are generated by simulating the system, in each case until it 236 
reaches equilibrium, for a range of values of the death rate µ, with other parameters fixed. As the 237 
death rate increases, the equilibrium-expected population size decreases and the relative size of the 238 
population fluctuations increase as measured by the coefficient of variation. For a given rate of 239 
disease transmission β, increasing the death rate reduces expected prevalence, and therefore 240 
simulating for different values of µ generates the range of prevalence values shown.  The resulting 241 
relationship between demography and expected prevalence for particular disease characteristics 242 
(here a fixed transmission rate, β) is illustrated in Figs 1a & 1b. These figures show increasing 243 
population size and lower demographic fluctuations as expected prevalence increases (i.e. as µ 244 
decreases).     245 
 246 
Fig. 1c shows the bias in the surveillance estimate of prevalence E[p̂surv] - E[p(t )] obtained from the 247 
same set of simulations. Results shown are based on 106 surveillance bouts with sample size m = 248 
10. The bias predicted by continuous sampling theory (which does not account for sample size) is 249 
also shown, and in this case accurately predicts simulated bias. Fig. 1c shows the bias in surveillance 250 
estimates of prevalence for four different transmission rates. For a given prevalence, populations 251 
associated with higher transmission rate (β) are more variable than those with lower transmission 252 
rate and therefore Fig. 1c shows that such variability increases the bias of surveillance estimates of 253 
disease prevalence. Fig. 1d shows the standard deviation in surveillance estimates of prevalence 254 
obtained from the same set of simulations. Comparison with the variability in prevalence estimates 255 
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expected under the zero fluctuation assumption reveals that fluctuations in our simulated wildlife 256 
disease system reduce the precision (increase the variance) of estimates obtained by surveillance. 257 
The variability of these estimates also increases with demographic fluctuations. Thus, in terms of 258 
prevalence estimation, the dynamics of the host–pathogen interaction are integral in determining 259 
the efficacy of surveillance. Assessment for a given system would require parameterization of 260 
demography and disease dynamic, but the bias and variance in prevalence estimates shown in Fig. 1 261 
are representative of a wide range of wildlife disease systems (see Materials and methods). 262 
 263 
Additional studies shown in Appendix S2 confirm the qualitative impact of fluctuations in population 264 
and prevalence seen in Fig. 1 are robust to sample and population size and mode of secondary 265 
transmission. Fig. S1 shows analogous results with sample size 100, where environmental variability 266 
drives fluctuations in a population around 100 times larger than considered above.  Fig. S3 shows 267 
results for simulation study 1 but where secondary transmission is frequency- (as opposed to 268 
density) dependent. Fig. S5 and Fig. S6 show results from simulation study 1 with sample sizes 20 269 
and 50 respectively. 270 
 271 
Surveillance design 272 
Based on simulation study 1a, Fig. 2 shows how the bias and variance of the estimate of prevalence 273 
changes as the intensity of surveillance (measured by the capture rate α) increases for fixed sample 274 
size (Figs 2a & 2c), and as the sample size, m, increases for a fixed capture rate (Figs 2b & 2d). For 275 
low capture rates, as α→0 (and based on a fixed sample size), the continuous sampling estimate 276 
given in eqn 1 provides an accurate prediction for the level of prevalence estimated from 277 
surveillance. As shown above, this is a biased estimate of the true prevalence E[p(t)]. However, 278 
increasing the capture rate reduces bias, and as α increases, this bias tends to zero. In addition, for 279 
large capture rates, the precision of the surveillance estimate of prevalence matches the variability 280 
of the underlying wildlife disease system (see Fig. 2c). Thus for low capture rates, the bias in 281 
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surveillance estimates of prevalence is well described by continuous sampling theory (eqn 1). 282 
However, for larger capture rates, the properties of the surveillance estimate of prevalence 283 
increasingly reflect both the expected true prevalence (i.e. bias reduces), and the variability in the 284 
prevalence of the underlying disease system. In contrast, increasing sample size improves precision, 285 
but not bias (Fig. 2b). In comparison to the predictions from the standard binomial approach (which 286 
neglects fluctuations), these have lower precision, and improve less quickly with increasing sample 287 
size (see Fig. 2d). Additional simulation results (not shown) indicate that as the sample size 288 
increases, the capture rate required to obtain unbiased estimates increases.  However, even for 289 
large sample sizes, when sampling is instantaneous (i.e. α→∞), the bias is zero and the standard 290 
deviation in the surveillance estimate of prevalence corresponds to that of the underlying wildlife 291 
disease system as shown above. 292 
 293 
We previously noted that capture rates for relatively intensely monitored populations (Delahay et al. 294 
2000; Hawkins et al. 2006) were between 0.5 and 2.2 with those of larger-scale studies (Brugman et 295 
al. 2013; Pounder et al. 2013; McGarry et al. 2014) lower still. Therefore, the results of Fig. 2 suggest 296 
fluctuations will lead to bias in surveillance-based estimates of prevalence for a wide range of 297 
wildlife disease systems. However, the size of these effects will be dependent on the details of host 298 
species demography and disease dynamics. 299 
 300 
The probability of detection  301 
If prevalence is assumed constant and equal to the long-term average prevalence E[p] of the wildlife 302 
disease system, then the probability that disease is detected in a sample of size m is given by: 303 
 304 
                   𝑃𝐷𝐵𝑖𝑛 = 𝑓(E[𝑝], 𝑚) =  1 − (1 − E[𝑝])𝑚                                   (eqn 2) 305 
 306 
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This formula, based on simple binomial arguments, and variants that also assume constant 307 
prevalence, are the standard basis for sample size calculations (see e.g. Fosgate 2009). However, if 308 
prevalence fluctuates PDBin is a misleading estimate of the probability of detection.  309 
 310 
When conducting surveillance prevalence will vary between the times when each of the m samples 311 
are collected, but we assume prevalence within a given surveillance bout is constant, and denote p. 312 
Fig. 3a indicates that accounting only for fluctuations between surveillance bouts is an accurate 313 
approximation.  Therefore, the expected probability of detection for sample size m is defined as     314 
 315 
                𝑃𝐷 = E[𝑓(𝑝, 𝑚)] =  E[1 − (1 − 𝑝)𝑚]                                (eqn 3) 316 
 317 
where the expectation is over the between-bout prevalence distribution P(p) which accounts only 318 
for prevalence fluctuations between surveillance bouts.  For a single sample  m = 1, eqn 3 reduces 319 
to a linear form, so that PD = PDBin = E[p]. However, if m > 1, then eqn 3 is non-linear, and 320 
therefore PD ≠ PDBin.   Further analysis of eqn 3 e.g. suggesting PD < PDBin, is shown in Appendix 321 
S4. 322 
 323 
Effect of host demography and transmission dynamics 324 
The results shown in Fig. 3 demonstrate the effect of host demography, transmission dynamics and 325 
surveillance design on the probability of detection. These results are obtained from the simulations 326 
described in Fig. 1, except for those in Fig. 3d where these simulations are rerun for different values 327 
of the capture rate (see study 1a in Materials and methods).  328 
 329 
Fig. 3b illustrates an analytic calculation of PD  based on approximating the between-bout 330 
prevalence distribution P(p) as a gamma distribution (see Appendix S4). Although, not completely 331 
successful, this does provide a more accurate prediction than PDBin. This approach could be used to 332 
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improve sample size calculations in situations where simulation is not possible, but information 333 
about prevalence fluctuations is available. Moreover, the results of Fig. 3a show that such 334 
approximations could be improved by assuming a more accurate representation of the prevalence 335 
distribution P(p). Crucially, these calculations support the conclusion that the true probability of 336 
detection is less than that obtained when ignoring fluctuations i.e. less than PDBin.  Fig. 3b also 337 
shows the impact of biased prevalence estimation on disease detection for the case β = 0.1. Fig. 1 338 
demonstrates that in this case, surveillance results in inflated estimates of prevalence E[p̂surv] > 339 
E[p(t)]. Ignoring the effect of fluctuations would therefore lead to an estimated detection 340 
probability greater than PDBin, which is based on the true average prevalence E[p]. 341 
 342 
Fig. 3c shows the effect of interactions between disease dynamics and demography. As in the case of 343 
prevalence estimation, conditioned on a given expected prevalence, larger contact rates β are 344 
associated with greater fluctuations in the underlying wildlife disease system (i.e. greater 345 
transmission rates are needed to sustain a given prevalence). Here larger fluctuations translate into 346 
reduced probability of detection. In Fig. 3c, for β = 1.0, the probability of detection is only a little 347 
above the line PD = E[p] ; this corresponds to a single sample m = 1.  Thus, in contrast to the zero 348 
fluctuation approximation PDBin, fluctuations reduce the effective sample size, for the β = 1.0 case 349 
from m = 10 to close to m = 1.  Results not shown indicate that the reduction in effective sample 350 
size increases with sample size (and see Fig. 4). Fig. 3d shows the effect of capture rate on the 351 
probability of detection; counterintuitively, more intense surveillance effort actually reduces the 352 
probability of detection. This is consistent with the above observations regarding β; less intense 353 
effort means that the required sample size takes longer to gather, which reduces between-bout 354 
fluctuations in prevalence.   355 
 356 
 357 
 358 
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Limits to disease detection in wildlife disease systems 359 
The nature of host demography and disease dynamics in wildlife disease systems will often be poorly 360 
understood especially in cases of emerging disease.  Fig. 4 is based on simulation study 2 (see 361 
Materials and methods) and shows the probability of detection associated with surveillance subject 362 
to demographic and disease fluctuations and  the zero fluctuation approximation PDBin. This is done 363 
for two different sampling levels, and across a broader range of wildlife disease systems than 364 
considered above, each represented by one of the points on the graph.  Depending on the level of 365 
fluctuations in the system, the effective sample size can range from the actual number of samples 366 
taken to m ≈ 1. These results suggest that, when designing surveillance, ignoring the effect of 367 
fluctuations could lead to studies that are underpowered in their ability to detect disease. These 368 
results are consistent with those of Fig. 3 based on the SDE implementation. 369 
 370 
Discussion 371 
This paper represents the first systematic exploration of the impact of pathogen transmission 372 
dynamics and demographic aspects of host ecology on wildlife disease surveillance efficacy. We have 373 
introduced a framework within which surveillance design is characterized by the capture rate (α), in 374 
addition to the standard sample size (m).  In this extended framework, the performance of 375 
surveillance is assessed in light of the ecology of the wildlife disease system of interest i.e. for 376 
particular population and disease parameters.  The framework introduced here can thus serve as a 377 
template for performing power calculations that account for fluctuations in populations and disease 378 
prevalence for specific hosts and pathogens. 379 
 380 
Our results show that surveillance design (choice of m and α) can have a large impact on bias and 381 
precision of prevalence estimation, and on the power to detect disease. With more unstable 382 
populations and greater fluctuations in disease, bias in prevalence estimates increases, and the 383 
precision of such estimates decreases. Such bias can be reduced by increasing capture rate, but for 384 
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fixed sample size this also reduces the ability to detect disease. However, results suggest that even 385 
in the most intensive wildlife disease surveillance programs (Delahay et al. 2000; Hawkins et al. 386 
2006) typical capture rates are not sufficient to eliminate bias. In contrast, increasing sample size 387 
does not affect bias, but does improve statistical power in terms of both precision of prevalence 388 
estimates and disease detection.  However, as sample size increases, such improvements in power 389 
are not as fast as would be expected if fluctuations were ignored, as they are in current surveillance 390 
design and analysis (Grimes & Schulz 1996; Dohoo, Martin & Stryhn 2005). 391 
 392 
Surveillance is a critical prerequisite for defining and controlling wildlife disease risks, and our results 393 
suggest that ignoring significant temporal fluctuations in the design of wildlife disease surveillance 394 
generates inadequate assessments of risk. Moreover, the ecology of many wildlife species and the 395 
pathogens to which they are exposed lead to significant temporal fluctuations in both population 396 
size and disease prevalence (Anderson & May 1979; Anderson 1991; Renshaw 1991; Wilson & 397 
Hassell 1997; Telfer et al. 2002; Hawkins et al. 2006).  The studies reported here were designed to 398 
explore these effects in a wide range of scenarios representative of actual surveillance in wildlife 399 
disease systems (see Materials and methods), and suggest that such issues are likely to be 400 
widespread.  A key aspect not accounted for in the work presented here is disease-induced mortality 401 
which preliminary results (not shown) suggest is likely to accentuate the effects shown here. 402 
Moreover, frequency-dependent transmission and fluctuations driven by environmental variation, 403 
studied only briefly here, also reduced the efficacy of surveillance. The framework presented could 404 
also be extended to account for known extrinsic sources of bias, such as imperfect disease 405 
diagnostics, variation in habitat quality (Nusser et al. 2008; Walsh & Miller 2010) and biased capture 406 
rates (Tuyttens et al. 1999) including aspects associated with passive surveillance.  407 
  408 
There is much current interest in quantifying risks from wildlife disease (Daszak, Cunningham & 409 
Hyatt 2000; Jones et al. 2008), and this is stimulating debate on the need to improve wildlife disease 410 
17 
 
surveillance (Bengis et al. 2004; Butler 2006; Gortázar et al. 2007; Béneult, Ciliberti & Artois 2014). 411 
This paper will help to further inform this debate, highlighting the need to consider the ecology of 412 
wildlife disease systems when designing or analysing surveillance programs (Béneult, Ciliberti & 413 
Artois 2014). This assessment emphasizes the importance of accounting for temporal 414 
heterogeneities induced by population fluctuations and disease dynamics. Further research is 415 
needed to assess the impacts of ecology on wildlife disease surveillance including alternative and 416 
complimentary heterogeneities such as intrinsic and extrinsic forms of spatial heterogeneity, and 417 
other population structures. There is a wealth of literature describing the effects of such 418 
heterogeneity in ecology and epidemiology (Lloyd & May 1996; Tilman & Kareiva 1997; Keeling, 419 
Wilson & Pacala 2000; Read & Keeling 2003; Keeling 2005; Vicente et al. 2007), and our results 420 
suggest that these are likely to have important, but as yet unexplored, impacts on the efficacy of 421 
wildlife disease surveillance.  422 
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Table 1: Model structure. Event, Rate and Effect on the State Space of the model. Conceptually the 546 
effect of each event affects an individual and this is reflected in the discrete nature of the 547 
corresponding changes in the state space. However, given this underlying conception of the model 548 
there are a number of different implementations which can be considered including via the Gillespie 549 
algorithm and stochastic differential equations (see text for details). 550 
551 Event Rate Effect 
Birth 𝑟𝑁(1 − 𝑁/𝑘) 𝑆 → 𝑆 + 1 
Death of Susceptible 𝜇𝑆 𝑆 → 𝑆 − 1 
Death of Infected 𝜇𝐼 𝐼 → 𝐼 − 1 
Susceptible Immigration  (1 − 𝛾) 𝜈 𝑆 → 𝑆 + 1 
Infected Immigration  𝛾𝜈 𝐼 → 𝐼 + 1 
Primary Transmission 𝛽0𝑆 𝑆 → 𝑆 − 1 
                 𝐼 → 𝐼 + 1 
Secondary Transmission 𝛽𝐼𝑆 𝑆 → 𝑆 − 1 
𝐼 → 𝐼 + 1 
Susceptible Active 
Capture and Release 
𝛼𝑆 𝑆 → 𝑆 
Infected Active Capture 
and Release 
𝛼𝐼   𝐼 → 𝐼 
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Figure 1: Effect of host demography and disease transmission. Data are shown for a range of values 575 
of the death rate µ which controls the stability and size of the population, and thus determines 576 
disease prevalence for a given transmission rate, β. For β=1 plot (a) shows that expected population 577 
size increases with expected prevalence E[p(t)] (i.e. as µ decreases) whilst (b) shows that the 578 
coefficient of variation of the population size decreases.  For the four values of β  indicated and 579 
fixed sample size m=10, (c) shows the bias E[p̂surv] - E[p(t )], and (d) the standard deviation in 580 
surveillance estimates of prevalence, versus the expected value of true disease prevalence in the 581 
system, E[p(t)]. Results shown are based on 106 surveillance bouts using the stochastic differential 582 
equation implementation of the model using the set of parameter values described in Appendix S2.   583 
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Figure 2: Effect of surveillance design. In all plots results are shown for three wildlife disease 608 
systems with (β, µ): (1, 0.43) solid lines; (1, 0.4) dashed; and (0.1, 0.43) dot-dashed. (a) and (b) 609 
show expected values of the surveillance estimate of prevalence (purple), the true prevalence (blue) 610 
and the continuous sampling theory prediction (black). (c) and (d) show the expected standard 611 
deviation (denoted, σp) in both the true (blue) and the surveillance estimated (purple) prevalence. 612 
(a) and (c) are plotted against a range of values of the capture rate α, for m = 10, and (b) and (d) 613 
versus a range of sample sizes m for α = 0.1. (d) also shows the constant prevalence estimate of the 614 
standard deviation based on the binomial (green). Parameter values used are as described in Table 615 
S3.  616 
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Figure 3: Effect of host–pathogen and surveillance dynamics on probability of detection.  Results 639 
based on simulations used for Figure 1 (for details see Table S4, Appendix S2). (d) estimated PD 640 
versus approximations based on modifcations of eqn 3 accounting for fluctuations in prevalance (i) 641 
within and between bouts and (ii) between bouts only. (c) shows PDBin based on both E[p] (green) 642 
and E[p̂surv] (black) and (for β = 0.1) PD and the approximation (eqn 4) based on an assumed 643 
gamma distribution.  (a) shows PDBin (green) and PD for various values of β  (as shown yellow (β = 644 
0.01); orange (β = 0.04); red (β = 0.1); purple (β = 1.0)) versus actual prevalence E[p]. (b) shows 645 
PDBin (green) and PD for β = 0.1 and the three capture rates α = 0.01, 1.0, 10.  In (a), (b) and (c) 646 
the black line indicates PD = E[p(t )].  647 
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Figure 4: Fluctuations reduce power to detect disease.   The two panels show the probability that 661 
disease is detected (conditional on non-zero prevalence) for target sample sizes 10 and 20. Each 662 
coloured dot represents the average of 100–1000 realizations of the model implemented using the 663 
Gillespie algorithm that met the sample target for a particular combination of parameters 664 
representing a distinct host–pathogen system (for details see Table S5, Appendix S2). The green 665 
dashed line in both graphs represents PDBin the probability of detection assuming constant 666 
prevalence (see eqn 2). It can be seen that PDBin generally overestimates the power of the sample in 667 
that it predicts a larger probability of detection than is realized in the stochastic simulations. 668 
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